Outcome of colorectal cancer in Diamond-Blackfan syndrome with a ribosomal protein S19 mutation.


Journal

Clinical journal of gastroenterology
ISSN: 1865-7265
Titre abrégé: Clin J Gastroenterol
Pays: Japan
ID NLM: 101477246

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 07 05 2020
accepted: 22 06 2020
pubmed: 10 7 2020
medline: 29 6 2021
entrez: 10 7 2020
Statut: ppublish

Résumé

Diamond-Blackfan anemia is an autosomal dominant syndrome, characterized by anemia and a predisposition for malignancies. Ribosomal proteins are responsible for this syndrome, and the incidence of colorectal cancer in patients with this syndrome is higher than the general population. This patient's Diamond-Blackfan anemia was caused by a novel ribosomal protein S19 gene mutation, and he received chemotherapy for colorectal cancer caused by it. In his cancer, ribosomal proteins S19 and TP53 were overexpressed. He received 5FU and cetuximab; however, his anemia made chemotherapy difficult, and he did not survive long. Patients with Diamond-Blackfan anemia should be screened earlier and more often for colorectal cancer than usual.

Identifiants

pubmed: 32643123
doi: 10.1007/s12328-020-01176-7
pii: 10.1007/s12328-020-01176-7
doi:

Substances chimiques

Ribosomal Proteins 0
ribosomal protein S19 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1173-1177

Auteurs

Kazuya Kimura (K)

Department of Clinical Oncology, Graduate School of Medicine, Akita University, Hirosaki University Graduate School of Medicine, Akita, Japan.

Kazuhiro Shimazu (K)

Department of Clinical Oncology, Graduate School of Medicine, Akita University, Hirosaki University Graduate School of Medicine, Akita, Japan.

Tsutomu Toki (T)

Department of Pediatrics, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.

Momoko Misawa (M)

Department of Pathology, Akita University Hospital, Akita, Japan.

Koji Fukuda (K)

Department of Clinical Oncology, Graduate School of Medicine, Akita University, Hirosaki University Graduate School of Medicine, Akita, Japan.

Taichi Yoshida (T)

Department of Clinical Oncology, Graduate School of Medicine, Akita University, Hirosaki University Graduate School of Medicine, Akita, Japan.

Daiki Taguchi (D)

Department of Clinical Oncology, Graduate School of Medicine, Akita University, Hirosaki University Graduate School of Medicine, Akita, Japan.

Sho Fukuda (S)

Department of Gastroenterology and Neurology, Graduate School of Medicine, Akita University, Akita, Japan.

Katunori Iijima (K)

Department of Gastroenterology and Neurology, Graduate School of Medicine, Akita University, Akita, Japan.

Naoto Takahashi (N)

Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Akita, Japan.

Etsuro Ito (E)

Department of Pediatrics, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.

Hiroshi Nanjyo (H)

Department of Pathology, Akita University Hospital, Akita, Japan.

Hiroyuki Shibata (H)

Department of Clinical Oncology, Graduate School of Medicine, Akita University, Hirosaki University Graduate School of Medicine, Akita, Japan. hiroyuki@med.akita-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH